Lautus Pharmaceuticals - GlyDerm Line's Unit Acquisition

Lautus Pharmaceuticals - GlyDerm Line raised a round of funding on July 26, 2016. Investors include Mission Pharmacal.

Lautus Pharmaceuticals aims to improve the health of patients' skin by providing superior esthetic and medical solutions to the dermatology market. GlyDerm is a line of skin care products from Lautus …

Articles about Lautus Pharmaceuticals - GlyDerm Line's Unit Acquisition: